Home > Balance Sheet > VENUS REMEDIES

VENUS REMEDIES
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹16 Cr₹11 Cr₹11 Cr₹-0.68 Cr₹3.63 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of VENUS REMEDIES ?

The latest Deferred Tax Assets / Liabilities ratio of VENUS REMEDIES is ₹16 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹16 Cr
Mar2024₹11 Cr
Mar2023₹11 Cr
Mar2022₹-0.68 Cr
Mar2021₹3.63 Cr

How is Deferred Tax Assets / Liabilities of VENUS REMEDIES Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹16 Cr
42.73
Mar2024 ₹11 Cr
2.54
Mar2023 ₹11 Cr
Positive
Mar2022 ₹-0.68 Cr
Negative
Mar2021 ₹3.63 Cr -

Compare Deferred Tax Assets / Liabilities of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹974.0 Cr -4.3% -7.6% 133.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,073.0 Cr -0% -3.2% -5% Stock Analytics
DIVIS LABORATORIES ₹175,657.0 Cr 4% 5.2% 11.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,121.0 Cr 2.4% 4.5% 18.3% Stock Analytics
CIPLA ₹118,431.0 Cr -3.5% -1.5% -2.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,944.0 Cr -3.2% -3.3% -10.6% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-4.3%

-7.6%

133.5%

SENSEX

-2.6%

-1.3%

7.2%


You may also like the below Video Courses